Related Experiment Videos
Effects of On-Site Supportive Communication Training in Oncology: A Multicenter Randomized Trial Assessing >3500
Kerstin Kiis Antonsen1,2, Signe Timm1,2, Johanne Dam Lyhne1,2
1Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Vejle, Denmark.
None:
To evaluate the effect of On-site Supportive Communication Training (On-site SCT) on patient-rated doctor communication in outpatient oncology. In this Danish multicenter randomized trial, 89 oncology doctors were assigned to On-site SCT or usual practice. The intervention included three training days over 3-4 months with real-time observation, structured reflection, and individualized feedback integrated into routine consultations. Patients attending baseline and follow-up consultations completed the validated 14-item Communication Assessment Tool (CAT). The proportion of patients rating doctor communication as "excellent" was the prespecified primary outcome. Of 3,989 patients, 3,562 completed the questionnaire. Core interpersonal behaviors were rated highly (68-73% "excellent"), while active engagement behaviors - eliciting patient ideas (69%), checking understanding (61%), and encouraging questions (58%) - were lower. No significant differences were observed between groups. On-site SCT did not improve patient-rated communication but identified priorities for future communication training. High baseline communication ratings and resulting ceiling effects may have limited detection of intervention effects. The study provides a large multicenter benchmark for PREMs and underscores methodological challenges in evaluating communication interventions.
Related Concept Videos
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Tumor Immunotherapy